Small-Cap Growth ETF (FYC) Hits New 52-Week High
- First Trust Small Cap Growth AlphaDEX Fund FYC: The fund hit a 52-week high and is up 29% from its low price, targeting the growth corner of small-cap stocks with key holdings in healthcare, industrials, and information technology.
- Market Outlook: The small-cap segment has been performing well due to renewed bets on rate cuts, which would benefit small-cap stocks reliant on debt financing and consumer spending.
- Zacks ETF Rank: FYC currently holds a Zacks ETF Rank #3 (Hold) with a High risk outlook, making it uncertain for future returns, but segments within the ETF have strong Zacks Industry Ranks.
- Investment Recommendations: Investors can receive key ETF information through Zacks' free Fund Newsletter and access the latest recommendations from Zacks Investment Research.
- Disclaimer: The views expressed are of the author and may not reflect those of Nasdaq, Inc.
Trade with 70% Backtested Accuracy
Analyst Views on FYC
About the author

FYC Share Price Analysis: FYC's share price is currently at $93.42, with a 52-week low of $59.2939 and a high of $96.64, indicating a relatively stable position within its trading range.
ETFs Trading Dynamics: Exchange traded funds (ETFs) function like stocks, allowing investors to buy and sell units that can be created or destroyed based on demand, impacting the underlying assets held within the ETFs.
ETF Target Price Analysis: The First Trust Small Cap Growth AlphaDEX Fund ETF (FYC) has an implied analyst target price of $104.03 per unit, indicating a potential upside of 14.43% from its current trading price of $90.91.
Notable Holdings with Upside: Key underlying holdings such as Privia Health Group Inc (PRVA), Huron Consulting Group Inc (HURN), and Arcutis Biotherapeutics Inc (ARQT) show significant upside potential based on analyst target prices, with expected increases of 20.70%, 16.18%, and 15.13% respectively.
ETF Performance: The ETF with the highest volume on Wednesday included Rigetti Computing, which rose by approximately 2.3% with over 21.7 million shares traded.
Other Notable Stocks: Terawulf experienced a slight decline of about 0.1% with over 13.1 million shares exchanged, while Impinj saw the most significant increase at around 5.6%.
Underperforming Component: Kymera Therapeutics was the weakest performer in the First Trust Small Cap Growth AlphaDEX Fund ETF, dropping by about 3.9%.
Disclaimer: The opinions expressed in the report are those of the author and do not necessarily represent Nasdaq, Inc.
Zeta Global's New AI Solutions: Zeta Global Holdings Corp. has launched an intelligent mobile experience for marketers, integrating AI to enhance personalized cross-channel campaigns and customer interactions, while also expanding its generative AI Agents on the Zeta Marketing Platform.
Market Performance and Insights: Following these announcements, ZETA shares rose by 1.82% to $30.20, with industry experts highlighting the importance of personalized marketing and AI infrastructure for improving performance and productivity in the coming years.
FYC ETF Performance: The Smallcap Growth Alphadex Fund (FYC) has reached a 52-week high, increasing by 44.91% from its low, driven by positive earnings and favorable U.S. economic indicators.
Future Outlook: With a Zacks ETF Rank of #3 (Hold) and a positive weighted alpha of 32.71, FYC is expected to maintain strong performance in the near term.
Overview of First Trust Small Cap Growth AlphaDEX ETF: Launched in 2011, the FYC ETF offers exposure to small-cap growth stocks using a smart beta strategy that selects stocks based on fundamental characteristics rather than market capitalization. It has approximately $328.59 million in assets and an annual expense ratio of 0.70%.
Performance and Alternatives: The fund has shown strong performance with a 25.24% increase over the past year but carries higher risk with a beta of 1.18. Investors may also consider lower-cost alternatives like the iShares Russell 2000 Growth ETF and Vanguard Small-Cap Growth ETF, which have significantly lower expense ratios.










